Charles S. Ryan, PRESIDENT at Quince Therapeutics, Inc. (QNCX), bought 48,387 shares at $0.65 ($31K) on 2024-08-20, disclosed to the SEC on 2024-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |